Opioid maker Insys files for bankruptcy in US
This is about a week after agreeing to pay $225m to settle a US probe into bribes it paid to doctors for prescribing fentanyl spray Subsys
10 June 2019 - 14:23
Boston, US — Drugmaker Insys Therapeutics filed for Chapter 11 bankruptcy protection on Monday, about a week after agreeing to pay $225m to settle a US probe into bribes it paid to doctors for prescribing a powerful opioid medication.
The filing in US Bankruptcy Court in the district of Delaware made Insys the first drug manufacturer to turn to bankruptcy due to legal expenses brought on by accusations of responsibility in the deadly US opioid epidemic. Shares of the company fell nearly 60% to 52 US cents in premarket trading...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.